Know Cancer

or
forgot password

    • cancer clinical trials in kennewick, WA

    • Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Columbia Basin Hematology
    Kennewick, Washington 99336
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Columbia Basin Hematology
    Kennewick, Washington 99336
    Breast Cancer
    Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers
    Columbia Basin Hematology and Oncology
    Kennewick, Washington 99336
    Carcinoma, Squamous Cell of the Head and Neck
    Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    Columbia Basin Hematology and Oncology
    Kennewick, Washington 99336
    Ovarian Cancer
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Phase 1 and 2 Study of PX-866 and Cetuximab
    Columbia Basin Hematology and Oncology
    Kennewick, Washington 99336
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer
    Columbia Basin Hematology and Oncology
    Kennewick, Washington 99336
    Locally Recurrent or Metatastic Breast Cancer ( HER2 Negative)
    Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
    Columbia Basin Hematology and Oncology
    Kennewick, Washington 99336
    Breast Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Columbia Basin Hematology
    Kennewick, Washington 99336
    Lymphoma
    EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
    Investigational Site Number 840603
    Kennewick, Washington 99336
    Ovarian Cancer Recurrent
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Columbia Basin Hematology
    Kennewick, Washington 99336
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Breast Cancer
    Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
    Columbia Basin Hematology and Oncology
    Kennewick, Washington 99336
    Non Small Cell Lung Cancer
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Non-squamous NSCLC
    Columbia Basin Hematology and Oncology
    Kennewick, Washington 99336
    Non-Squamous Cell Non-small Cell Lung Cancer
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma
    Columbia Basin Hematology and Oncology
    Kennewick, Washington 99336
    Hodgkin Lymphoma
    A Phase 2 of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
    Columbia Basin Hematology and Oncology
    Kennewick, Washington 99336
    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Indolent Non-Hodgkin's Lymphoma
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Columbia Basin Hematology
    Kennewick, Washington 99336
    Melanoma (Skin)
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Columbia Basin Hematology
    Kennewick, Washington 99336
    Esophageal Cancer
    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Recurrent Melanoma, Stage IV Melanoma
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma
    S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
    Columbia Basin Hematology
    Kennewick, Washington 99336
    Head and Neck Cancer
    Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy
    Investigational Site Number 840063
    Kennewick, Washington 99336
    Venous Thromboembolism, Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    S0309, Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance
    Columbia Basin Hematology
    Kennewick, Washington 99336
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    Columbia Basin Hematology
    Kennewick, Washington 99336
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Columbia Basin Hematology
    Kennewick, Washington 99336
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
    Columbia Basin Hematology and Oncology PLLC
    Kennewick, Washington 99336
    Light Chain Deposition Disease, Primary Systemic Amyloidosis
    Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
    Columbia Basin Hematology and Oncology
    Kennewick, Washington 99336
    Lung Neoplasms, Carcinoma, Cancer of the Lung, Non-Small-Cell Lung Carcinoma